Cargando…

Editorial: New Trends in the Renin-Angiotensin-Aldosterone System in Cardiovascular Disease

Detalles Bibliográficos
Autores principales:	Szczepanska-Sadowska, Ewa, Rossi, Noreen F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637739/ https://www.ncbi.nlm.nih.gov/pubmed/34867424 http://dx.doi.org/10.3389/fphar.2021.790439

Ejemplares similares

Dysregulation of the Renin-Angiotensin System and the Vasopressinergic System Interactions in Cardiovascular Disorders
por: Szczepanska-Sadowska, Ewa, et al.
Publicado: (2018)

Stroke, High Blood Pressure and The Renin–Angiotensin–Aldosterone System – New Developments
por: Atkinson, Jeffrey
Publicado: (2011)

The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19
por: Mascolo, Annamaria, et al.
Publicado: (2021)

Systematic Review and Meta-Analysis of Renin–Angiotensin–Aldosterone System Blocker Effects on the Development of Cardiovascular Disease in Patients With Chronic Kidney Disease
por: Yanai, Katsunori, et al.
Publicado: (2021)

Renin–angiotensin–aldosterone pathway modulators in chronic kidney disease: A comparative review
por: Alshahrani, Saeed
Publicado: (2023)

The Impact of the Renin-Angiotensin-Aldosterone System on Inflammation, Coagulation, and Atherothrombotic Complications, and to Aggravated COVID-19
por: Ekholm, M., et al.
Publicado: (2021)

The effect of eplerenone on the renin‐angiotensin‐aldosterone system of rats with thyroid dysfunction
por: Dizaye, Kawa, et al.
Publicado: (2019)

Cardiovascular Risk Reduction with Renin-Angiotensin Aldosterone System Blockade
por: Houston Miller, Nancy
Publicado: (2010)

Multiple Aspects of Inappropriate Action of Renin–Angiotensin, Vasopressin, and Oxytocin Systems in Neuropsychiatric and Neurodegenerative Diseases
por: Szczepanska-Sadowska, Ewa, et al.
Publicado: (2022)

The Renin–Angiotensin–Aldosterone System and Coronavirus Disease 2019
por: Coto, Eliecer, et al.
Publicado: (2021)

The renin‐angiotensin‐aldosterone system, neurohumoral axis and cardiovascular mortality in LURIC
por: Yazdani, Babak, et al.
Publicado: (2022)

Emergence and evolution of the renin–angiotensin–aldosterone system
por: Fournier, David, et al.
Publicado: (2012)

Beyond the Circulating Renin–Angiotensin Aldosterone System
por: De Mello, Walmor C.
Publicado: (2014)

The renin‐angiotensin‐aldosterone system and its suppression
por: Ames, Marisa K., et al.
Publicado: (2019)

The renin angiotensin aldosterone system and COVID-19
por: Alsufyani, Hadeel A., et al.
Publicado: (2020)

Interactions of the DASH Diet with the Renin-Angiotensin-Aldosterone System
por: Maris, Stephen A, et al.
Publicado: (2019)

Targeting Renin–Angiotensin System Against Alzheimer’s Disease
por: Gebre, Abadi Kahsu, et al.
Publicado: (2018)

The Renin-Angiotensin-Aldosterone System in Metabolic Diseases and Other Pathologies
por: Ortiz, Rudy M., et al.
Publicado: (2023)

Role of the Renin-Angiotensin System and Aldosterone on Cardiometabolic Syndrome
por: Stiefel, P., et al.
Publicado: (2011)

The Renin-Angiotensin-Aldosterone System in Vascular Inflammation and Remodeling
por: Pacurari, Maricica, et al.
Publicado: (2014)

Independent regulation of renin–angiotensin–aldosterone system in the kidney
por: Nishiyama, Akira, et al.
Publicado: (2018)

Management of proteinuria: blockade of the renin–angiotensin–aldosterone system
por: Athavale, Akshay, et al.
Publicado: (2020)

Inhibitors of the Renin–Angiotensin–Aldosterone System and Covid-19
por: Jarcho, John A., et al.
Publicado: (2020)

Erratum for The renin‐angiotensin‐aldosterone system and its suppression
Publicado: (2019)

Renal Modulation: The Renin-Angiotensin-Aldosterone System (RAAS)
por: Natarajan, Aruna, et al.
Publicado: (2008)

Renin-angiotensin-aldosterone system and COVID-19 infection
por: Alexandre, Joachim, et al.
Publicado: (2020)

Covid-19, hypokalaemia and the renin-angiotensin-aldosterone system
por: Mandal, Amit.K.J., et al.
Publicado: (2021)

The Retinal Renin-Angiotensin-Aldosterone System: Implications for Glaucoma
por: Hirooka, Kazuyuki, et al.
Publicado: (2022)

Sex differences in the renin-angiotensin-aldosterone system and its roles in hypertension, cardiovascular, and kidney diseases
por: Nwia, Sarah M., et al.
Publicado: (2023)

Role of MicroRNAs in Renin-Angiotensin-Aldosterone System-Mediated Cardiovascular Inflammation and Remodeling
por: Pacurari, Maricica, et al.
Publicado: (2015)

Cardiovascular Damage in COVID-19: Therapeutic Approaches Targeting the Renin-Angiotensin-Aldosterone System
por: Lumpuy-Castillo, Jairo, et al.
Publicado: (2020)

Renin-Angiotensin-Aldosterone Inhibitors and COVID-19
por: Benenson, Irina, et al.
Publicado: (2020)

Recent Update of Renin-angiotensin-aldosterone System in the Pathogenesis of Hypertension
por: Moon, Ju-Young
Publicado: (2013)

Advances in the Renin-Angiotensin-Aldosterone System: Relevance to Diabetic Nephropathy
por: Koitka, Audrey, et al.
Publicado: (2008)

The Renin‐Angiotensin‐Aldosterone System in Greyhounds and Non‐Greyhound Dogs
por: Martinez, J., et al.
Publicado: (2017)

The Interplay Between the Renin-Angiotensin-Aldosterone System and Parathyroid Hormone
por: Zheng, Ming-Hui, et al.
Publicado: (2020)

Effect of renal denervation on catecholamines and the renin–angiotensin–aldosterone system
por: Feyz, Lida, et al.
Publicado: (2020)

Renin-angiotensin-aldosterone system and kidney interactions in heart failure
por: Ferreira, João Pedro, et al.
Publicado: (2019)

Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
por: Vaduganathan, Muthiah, et al.
Publicado: (2020)

Hypertension, renin–angiotensin–aldosterone system inhibition, and COVID-19
por: Williams, Bryan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_iufeecq5118g69h84vttog09br